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High-fat diets stimulate inflammation in
the brain that is implicated in obesity.
Here, Valdearcos et al. identify
hypothalamic microglia as sensors of
saturated fat that orchestrate local
inflammation when dietary intake is high.
In this context, microglia mediate the
impact of saturated fat on leptin
responsiveness and regulate food intake.
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Diets rich in saturated fat produce inflammation, glio-
sis, and neuronal stress in the mediobasal hypothal-
amus (MBH). Here, we show that microglia mediate
this process and its functional impact. Although mi-
croglia and astrocytes accumulate in the MBH of
mice fed a diet rich in saturated fatty acids (SFAs),
only the microglia undergo inflammatory activation,
along with a buildup of hypothalamic SFAs. Enteric
gavage specifically with SFAs reproduces microglial
activation and neuronal stress in the MBH, and SFA
treatment activates murine microglia, but not astro-
cytes, in culture. Moreover, depleting microglia abro-
gates SFA-induced inflammation in hypothalamic
slices. Remarkably, depleting microglia from the
MBH of mice abolishes inflammation and neuronal
stress induced by excess SFA consumption, and in
this context, microglial depletion enhances leptin
signaling and reduces food intake. We thus show
that microglia sense SFAs and orchestrate an inflam-
matory process in the MBH that alters neuronal func-
tion when SFA consumption is high.
INTRODUCTION
Fatty acids (FAs) serve as energy substrates and as signals
controlling metabolic processes. For example, dietary FAs
signal through intestinal G protein-coupled receptors to stim-
ulate pancreatic insulin secretion (Talukdar et al., 2011).
FAs also act in the brain. In particular, the mediobasal hypo-
thalamus (MBH), including the arcuate nucleus (ARC) and
median eminence (ME), can sense FAs and transduce this
to control food intake, thermogenesis, and intermediary meta-
bolism (Lam et al., 2005). The fenestrated nature of the blood-
brain barrier (BBB) surrounding the MBH may facilitate this
capacity.2124 Cell Reports 9, 2124–2138, December 24, 2014 ª2014 The AutHowever chronic consumption of FAs, particularly when satu-
rated, leads to inflammation in the white adipose tissue, liver,
and skeletal muscle that is implicated in the pathogenesis of
metabolic diseases including type 2 diabetes (Bergman and
Ader, 2000), nonalcoholic steatohepatitis (de Almeida et al.,
2002), and atherosclerosis (Singh et al., 2002). Chronic ‘‘meta-
bolic inflammation,’’ marked by macrophage accumulation,
has been targeted to mitigate diseases linked to overnutrition
(Dali-Youcef et al., 2013).
Diet-induced obesity also produces metabolic inflammation
in the MBH (Thaler et al., 2012), and work targeting TLR4,
tumor necrosis factor a (TNF-a), NF-kB, and NLRP3 suggests
that controlling inflammation in the MBH can limit metabolic
complications of diet-induced obesity (Milanski et al., 2012;
Zhang et al., 2008; Vandanmagsar et al., 2011). Reaching
this objective, however, requires identifying what factors
trigger inflammation in the MBH and the responsive cell types
that mediate this process.
Treating cultured macrophages with long-chain saturated FAs
(SFAs), but not unsaturated species, stimulates an inflammatory
response reminiscent of what occurs in tissues responding to di-
etary excess, and feeding mice diets rich in SFAs induces insulin
resistance (Kennedy et al., 2009). Interestingly, dietary SFAs
also exert proinflammatory effects in the MBH that are linked
to impaired control over peripheral metabolism (Milanski et al.,
2012; Ross et al., 2010), but it is unknown which cell type(s)
mediate this process.
Metabolic inflammation in the MBH is marked by accumula-
tion of astrocytes and microglia, the CNS analogs of macro-
phages. Based on the role of macrophages in metabolic inflam-
mation, it is intriguing to consider targeting microglia to control
CNS metabolic inflammation. However, microglial responses
to FAs are not understood, and tools tomanipulate hypothalamic
microglia have been lacking.
Here, we use new approaches to both enrich and deplete mi-
croglial content in the MBH of mice in order to demonstrate their
unique inflammatory responsiveness to enteric SFAs. By doing
so, we identify microglia as sensors that dictate the intensity of
metabolic inflammation in the MBH and mediate key changeshors
in hypothalamic function that occur in response to consuming
excess saturated fat.
RESULTS
Excessive Dietary SFA Consumption Specifically
Activates Microglia in the MBH, which Is Mirrored by
Hypothalamic SFA Accumulation
Rats express classical (M1) inflammatory markers and develop
hypothalamic gliosis when consuming excess dietary fat for as
little as 7 days (Thaler et al., 2012). To examine the role of
long-chain dietary SFAs in triggering metabolic inflammation in
theMBH, we fed 10-week-old mice a high-fat diet (HFD) in which
42% of calories were from milk fat, which is highly enriched in
SFAs (mostly C16:0 palmitic [PA] and C18:0 stearic acids) for
1, 4, and 16 weeks.
Mice consuming this SFA-rich HFD accumulated microglia
(and astrocytes; not shown) in the MBH, reaching a plateau by
4weeks (Figures 1A and 1B). Thesemicroglia displayedmorpho-
logical features of M1 activation (Figures 1A and 1B). We also
measured hypothalamic inflammation in this setting by staining
for TNF-a, an M1 cytokine that when neutralized in the brain pro-
duced beneficial metabolic effects in high-fat-fed mice (Milanski
et al., 2012). High-fat feeding increased TNF-a in the MBH, and
this colocalized strongly with microglia (Iba1+ cells), but not at all
with cells expressing the astrocytemarker GFAP (Figures 1C and
1D). Moreover, the HFD specifically increased the mRNA levels
of M1 genes in the hypothalamus, and this increase was retained
when only hypothalamic microglia were analyzed (Figure 1E).
Together, these findings indicate that hypothalamic microglia
specifically undergo inflammatory activation in mice consuming
a diet rich in SFAs, marking a form of diet-induced metabolic
inflammation that is localized to the MBH.
To determine whether dietary SFAs activate hypothalamic
microglia directly, we first tested the impact of consuming
excess dietary SFAs on lipid levels in the brain. A targeted anal-
ysis of lipids extracted from the hypothalami and cerebral
cortices of mice consuming standard chow or the SFA-rich
HFD for 28 days revealed that a minority of analytes were altered
by high-SFA feeding (Figure S1). Of these, most were either
altered similarly in both the cortex and hypothalamus or only
in the cortex with hypothalamic levels trending in the same direc-
tion (Figure S1). On the other hand, high dietary SFA intake
specifically increased hypothalamic SFA levels. PA, the most
abundant lipid in the SFA-rich HFD, was the only species the
level of which was increased solely in the hypothalamus, and
this increase (40% over chow) was the largest of any FA in
either the hypothalamus or cortex (Figure 1E). These findings
indicate that dietary SFAs build up in the hypothalamus when
consumed in excess, and they prompted us to wonder whether
this buildup could trigger microglial activation in the MBH.
Enteric SFAs Trigger Microglial Activation in the MBH
Independent of Caloric Intake
To determine whether consuming excess SFAs stimulates M1
activation of MBH microglia independently of its effect on body
weight, we providedmice with a variety of FAs by enteric gavage
while holding total fat and caloric intake constant. We first pro-Cell Revided mice with clarified milk fat (primarily PA) that included a
radioactive (14C-PA) label. In this context, we observed a rapid
flux of PA into the hypothalamus and cortex, with kinetics similar
to those for PA flux into peripheral tissues (Figure S2A). These
findings indicate that the brain, including the hypothalamus, is
a site for postprandial flux of enteric SFAs. Moreover, increasing
daily milk fat consumption enhanced PA flux into the brain as it
did in other tissues, mirroring what was seen with the HFD
(Figure S2A).
The rapidity with which enteric PA fluxed into the hypothala-
mus suggested that it might be transported there by postpran-
dial lipoproteins. We therefore tested whether hypothalamic
microglia take up lipoprotein-associated lipids by injecting
mice with very low-density lipoproteins (VLDLs) containing lipids
labeled with a fluorescent lipophilic dye (DiI). Hypothalamic mi-
croglia took up the DiI within 1 hr of VLDL injection, and this
increased over 6 hr, indicating that lipoprotein-associated lipids
rapidly access the MBH and that microglia take up these lipids
(Figure S2B).
In concert with its flux into the brain, milk fat gavage for
3 days also remarkably increased the hypothalamic levels of
M1 markers (Figure 2A) and induced accumulation of MBH mi-
croglia with features of activation resembling those in mice fed
a high-SFA diet (Figure 2B). Moreover, this short-term SFA
gavage did not increase TNF-a, MCP-1, or interleukin-6 (IL-6)
levels in the blood, indicating that the effects in the MBH were
not due to systemic inflammation (data not shown). By contrast,
isocaloric gavage with olive oil (primarily oleic acid [OA]) did not
induce either the transcription of M1 genes (Figure 2A) or the
accumulation of microglia in the MBH (Figure 2B). Taken
together, these findings indicate that excess dietary SFA intake
directly triggers hypothalamic metabolic inflammation, and is
not a byproduct of increased total fat or caloric intake, or inflam-
mation elsewhere in the body.
As with a chronic high-SFA diet, enteric milk fat gavage mark-
edly increased TNF-a in the MBH, and this again localized to mi-
croglia (Figure 2C), but not astrocytes (Figure 2D), confirming
that microglia are uniquely responsive to SFAs in initiating meta-
bolic inflammation. Gavage with coconut oil (mainly short-chain
SFA), on the other hand, stimulated a response in between that
of olive oil and milk fat (Figure 2A), indicating that some of the
proinflammatory effects of dietary SFAs may be a function of
chain length.
Excess Enteric SFA Consumption Induces Neuronal
Stress in the MBH
Consumption of a HFD induced expression of heat-shock pro-
tein 72 (Hsp72), a chaperone involved in the response to
neuronal stress (Sharp et al., 1999), in the MBH of rats (Thaler
et al., 2012).We found that feedingmice a SFA-rich HFD induced
Hsp72 in neurons specifically in the MBH (Figure 2E), a response
rapidly reproduced by administering milk fat to chow-fed mice
by enteric gavage (Figure 2E). By contrast, gavage with OA-
rich olive oil did not induce neuronal Hsp72, even though both
olive oil and milk fat increased daily fat intake by 38% (Fig-
ure 2E). Thus, increased SFA intake, and not fat intake per se, ac-
counts for the stress response of neurons in the MBH to excess
saturated fat consumption.ports 9, 2124–2138, December 24, 2014 ª2014 The Authors 2125
Figure 1. High-Fat Diet Induces the Inflammatory Activation of Microglia Specifically in the Hypothalamic ARC
(A) Increased ARC staining of Iba1 in hypothalamic sections from mice fed an HFD for 4 weeks (3V, third ventricle).
(B) Quantification of ARC microglial number and size in (A) (n = 5/group; data shown are mean values ± SEM; *p < 0.05 versus chow).
(C and D) Representative immunostained ARC sections illustrating diet-induced induction of TNF-a and its strong colocalization with Iba1 (see also inset), but not
GFAP (D).
(E) Quantitative PCR analysis showing increasedmRNA levels of M1mediators, cytokines, and chemokines in whole hypothalami andmicroglial fractions of mice
fed a 4-week HFD (n = 5/group; data shown are mean values ± SEM; *p < 0.05 versus chow).
(F) Fold change in individual FA levels (liquid chromatography-mass spectrometry) in the cerebral cortices (CTX) and hypothalami (HYPO) of mice following
4 weeks of HFD (n = 5/group; data shown are mean values ± SEM; *p < 0.05 versus CTX).
See also Figure S1.Moreover, the neuronal stress response to gavage with SFAs
involved neurons in the ARC that phosphorylate STAT3 upon
systemic leptin treatment (Figure 2F), suggesting that excessive
SFA consumptionmay impact the leptin-responsive neurocircui-
try of the MBH.2126 Cell Reports 9, 2124–2138, December 24, 2014 ª2014 The AutLong-Chain SFAs Exert Direct and Specific
Inflammatory Effects on Microglia
Given that dietary SFAs accumulate in the hypothalami of
mice and induce M1 microglial activation in the MBH even
when their intake is dissociated from caloric excess, wehors
Figure 2. SFA Gavage Reproduces Diet-Induced Hypothalamic Inflammation and Neuronal Stress in Mice
(A) IncreasedmRNA levels ofM1markers in theMBHofmice receiving isocaloric OA (C18:1; olive oil), lauric acid (C12:0; coconut oil), or PA (C16:0; milk fat) versus
saline by enteric gavage twice daily for 3 days (n = 4/group; data shown are mean values ± SEM; *p < 0.05 versus control).
(B) Increased Iba1 staining in the ARC of mice receiving milk fat (versus olive oil) by gavage as above.
(C and D) Immunostaining showing specific TNF-a induction in the ARC by milk fat gavage and colocalization with Iba1 (C), but not GFAP (D).
(E) Induction of Hsp72 in NeuN+ cells specifically in the ARCby feedingmice a 4-week high-SFA diet or bymilk fat by gavage for 3 days (versus chow diet and olive
oil gavage, respectively; n = 4/group).
(F) Hypothalamic sections from mice receiving milk fat gavage as in (E), and 45 min after subsequent treatment with i.p. leptin. A representative section reveals
leptin-induced pSTAT3 and milk fat-induced Hsp72 simultaneously in individual ARC neurons (see arrows; n = 4/group).
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Figure 3. Long-Chain Dietary SFAs Specifically Stimulate the Inflammatory Activation of Primary Microglia
(A) M1 cytokine secretion (ELISA) by primarymurinemicroglia treated for 24 hr with 100 mMof the listed FAs (n = 3/group; data shown aremean values ±SEM; *p <
0.05 versus BSA).
(B and C) Representative immunoblots showing phosphorylation of (B) IKK-b and (C) p65 (Rel-A) induced specifically by treatment with SFAs between 100 and
300 mM (total protein and GAPDH as loading controls).
(D) Immunostaining for GFAP (green), CD11b (red), and DAPI (blue) in primary astrocyte cultures treated for 72 hr with a control liposome (Lip-C) or Lip-CLO
(200 ng/ml) showing microglial elimination.
(E) Differential M1 cytokine secretion bymicroglia and astrocytes treated for 24 hr with PA (100 mM). LPS andOAwere positive and negative controls, respectively
(n = 3/group; data shown are mean values ± SEM; *p < 0.05 or **p < 0.01 versus astrocytes).
See also Figure S3.sought to determine if SFAs directly activate microglia. We
measured cytokine release by primary murine microglia
treated with FAs of varying chain lengths and saturation
status for 24 hr. We found that only SFA treatment induced
M1 cytokine secretion by microglia and that long-chain
SFAs were generally more potent than short-chain SFAs (Fig-
ure 3A). Similarly, only SFA treatment activated NF-kB, a tran-
scription factor for M1 genes, as measured by monitoring
the phosphorylation both IKKb (p-IKKb) and the p65 subunit
of NF-kB (p-RelA) (Figure 3B). Indeed, PA treatment dose-
dependently increased p-RelA between 100 and 300 mM (Fig-
ure 3C). These findings indicate that long-chain SFAs directly
stimulate microglial M1 activation at concentrations that might2128 Cell Reports 9, 2124–2138, December 24, 2014 ª2014 The Autbe reached in the hypothalami of mice consuming excess
dietary fat.
We next examined whether SFAs can activate astrocytes,
another glial cell type accumulating in the MBH of mice
consuming an SFA-rich diet. We first eliminated microglia
from freshly harvested, astrocyte-enriched, mixed glial cul-
tures by treatment with liposomal clodronate (Lip-CLO;
100 mg/ml) or used diphtheria toxin (DT; 20 ng/ml) to treat
similar cultures harvested from mice expressing the human
diphtheria toxin receptor (DTR; also known as hbEGF) under
control of the CD11b promoter (CD11b-DTR). Immunostain-
ing clearly revealed that both strategies eliminated micro-
glia, leaving behind a pure population of GFAP+ cells withouthors
Figure 4. Microglial Depletion Abolishes the Inflammatory Response of Hypothalamic Slice Cultures to SFA Treatment
(A) Immunostaining for Iba1 (green) and NeuN (red) in 5-day-old hypothalamic slices cultures treated with either Lip-C or Lip-CLO (3 days) showing profound
microglial depletion.
(B and C) Quantitative PCR analysis of (B) Lip-C and Lip-CLO-treated WT slice cultures and (C) DT-treated CD11b-DTR and WT slice cultures showing reduced
mRNA levels of microglial markers (Iba1, CD68, Itgam), but not astrocyte (Gfap) or neuronal (Agrp, Npy) markers.
(D and E)Microglial depletion by (D) Lip-CLO treatment (WT) or (E) DT treatment (CD11b-DTR) specifically abolishesM1 cytokine secretion by hypothalamic slices
treated with 100 mM PA or OA. BSA, negative control; LPS, positive control.
Data shown are mean values ± SEM; n = 3/group; *p < 0.05 or **p < 0.01 versus control or as indicated. See also Figure S4.discernable impairment in viability (Figures 3D and S3A). Pri-
mary astrocytes and microglia from the same mice were
treated with vehicle (BSA), OA, PA, or lipopolysaccharide
(LPS) as a control, respectively. Whereas PA treatment
induced M1 cytokine secretion from microglia, this response
was nearly absent in astrocytes (Figures 3E and S3B), illus-
trating that microglia directly and specifically respond to
long-chain SFAs (e.g., PA) and supporting their role as CNS
sensors capable of initiating inflammation in response to rising
SFA levels in the MBH.
Microglia Are Responsible for the Inflammatory
Response of Hypothalamic Slice Cultures to PA
Treatment
To test the direct role of microglia in FA-driven hypothalamic
inflammation, we first depleted microglia from 300-mM-thick
murine organotypic hypothalamic slice cultures using Lip-CLO.Cell ReMicroglial depletion was confirmed by documenting a greater
than 90% loss of Iba1+ cells versus control (Figure 4A) and a
marked reduction in the mRNA levels of microglial markers,
including Aif1/Iba1, CD68, and Itgam/CD11b (Figure 4B). More-
over, the effects of Lip-CLO treatment were specific, as no
changes were seen in the numbers of NeuN+ mature neurons
(Figure 4A) or in the mRNA levels of Gfap (astrocyte marker) or
either Agrp or Npy (specific neuropeptides) (Figure 4B). Treating
hypothalamic slices cultured from CD11b-DTR mice with DT
produced similar results (Figure 4C).
PA treatment, versus treatment with vehicle or OA, stimu-
lated M1 cytokine secretion from hypothalamic slice cultures,
and microglial depletion nearly abolished this response (Figures
4D and 4E), indicating that microglia are essential for SFA-
driven hypothalamic metabolic inflammation. On the other
hand, microglial depletion only modestly reduced the inflamma-
tory response to LPS treatment, indicating that nonmicroglialports 9, 2124–2138, December 24, 2014 ª2014 The Authors 2129
cell types may contribute to the response to other inflammatory
stimuli.
Specifically Depleting Hypothalamic Microglia in Mice
In attempting to manipulate microglial content in the MBH of
mice, we first lethally irradiated adult CD11b-DTR and wild-
type (WT) (control) mice while shielding their heads and necks
with lead in order to protect the BBB from irradiation-induced
disruption (Figure S5A). We then reconstituted the bone marrow
of these mice with hematopoietic cells from WT mice in which
red fluorescent protein (RFP) was expressed under control of
the C-C chemokine receptor 2 (CCR2) promoter (CCR2-RFP).
The resulting mice (DTRBMT) expressed DTR in microglia, but
not in donor-derived cells, the CCR2+ monocytes of which could
be tracked by monitoring RFP. After recovering for 6 weeks, we
used fluorescence-activated cell sorting (FACS) to confirm
that >90% of CD11b+ cells in the blood of both DTRBMT mice
and WTBMT controls were also RFP+, indicating high reconsti-
tution efficiency (Figure S5B). In this way, we were able to
confine DTR expression to microglia and exclude its expression
from peripheral immune cells. Moreover, whereas RFP-labeled
monocytes infiltrated the brains of transplanted mice that
were not head-shielded during irradiation, head shielding elimi-
nated such posttransplant monocyte infiltration over 8 weeks
(Figure S5C).
DTRBMT and WTBMT mice were either treated with intraperito-
neal (i.p.) vehicle (control) or DT (10 ng/g body weight) daily for
3 days, and the microglia from hypothalamic sections were
analyzed by immunostaining 24 hr after the last injection. As
expected, the number and morphology of hypothalamic Iba1+
microglia was unaffected in WTBMT and DTRBMT mice treated
with vehicle or in WTBMT mice receiving DT (Figures 5A and
5B). By contrast, treating DTRBMT mice with DT reduced the
number of Iba1+ cells in the MBH by 60% and the mRNA
levels of microglial markers in the MBH by 50% (Figures
5A–5C). On the other hand, DT-treated DTRBMT mice had no
alteration in hypothalamic levels of the astrocyte marker
Gfap, indicating specific depletion of microglia (Figure 5C).
DT-induced depletion of hypothalamic microglia in DTRBMT
mice was also associated with gross alterations in microglial
morphology (Figure 5A) and with microglial apoptosis (coloc-
alization of TUNEL+ and Iba1+ cells) not seen in controls
(Figure S5D). Microglial depletion in DT-treated DTRBMT mice
was also specific to the MBH and not seen in the cortex or hip-
pocampus (Figure S6A), likely owing to more effective transit of
DT into the MBH versus other brain regions under the condi-
tions of this study.
Manipulating the Number of Microglia in the MBH of
DTRBMT Mice
Bromodeoxyuridine (BrdU) labeling of DT-treated DTRBMT mice
revealed that microglial depletion was followed within 72 hr of
the final dose of DT by proliferation (Figures 5D and 5E), leading
to a re-emergence ofMBHmicroglia within 5 days. These BrdU+/
Iba1+ cells did not express RFP, indicating they did not arise from
donor-derived monocytes and supporting the concept that adult
microglia can self-renew and maintain their own numbers within
the CNS (Ajami et al., 2007; Elmore et al., 2014).2130 Cell Reports 9, 2124–2138, December 24, 2014 ª2014 The AutInterestingly, postdepletive microglial proliferation in the
MBH of DT-treated DTRBMT mice resulted over 10 days in
increased microglial numbers, both over baseline and vehicle-
or DT-treated controls (Figures S5E and S5F). As for the initial
depletion, the postdepletive increase in microglial content was
specific to the MBH (Figures S5G and S6A). Moreover, the mi-
croglia that accumulated in the MBH were not M1 activated,
but rather had features similar to those of microglia in the MBH
of chow-fed controls (Figure S6B). Thus simply increasing the
basal number of microglia in the MBH of chow-fed mice is not
sufficient to induce inflammation. On the other hand, postdeple-
tive microglial proliferation was associated with increases in hy-
pothalamic mRNA levels of the chemokine gene Ccl2 (MCP-1;
Figure S6B), which was shown to induce microglial proliferation,
but not M1-type activation, in vitro (Hinojosa et al., 2011). Over-
all, this process allowed us to generate mice with an increased
basal number of quiescent of microglia, specifically in the MBH.
Supporting the tissue-autonomous self-renewing capacity of
microglia (Eliason et al., 2002), postdepletive microglial prolifer-
ation also occurred in hypothalamic slices, restoring microglial
content within 8 days of Lip-CLO-induced depletion (Figures
S4A and S4B). Moreover, postdepletive re-emergence of hypo-
thalamic microglia, which occurred without altering mRNA levels
of astrocyte- or neuronal markers, restored the responsiveness
of hypothalamic slices to PA and LPS treatment (Figure S4C),
underscoring the key role of microglia in triggering hypothalamic
inflammation.
To stabilize microglial depletion in the MBH, we adminis-
tered DTRBMT mice a specific BBB-permeable colony-stimu-
lating factor 1 receptor (CSF1R) antagonist (Ki20227, 30 mg/
kg) by gavage following DT-induced MBH microglial depletion.
CSF1R blockade dramatically reduced postdepletive MBH mi-
croglial proliferation in DTRBMT mice, assessed by the number
of both Iba1+ and Iba1+/BrdU+ cells in hypothalamic sections
versus control (Figures 5D and 5E). Concordantly, hypothalamic
microglial mRNA levels in DT-treated DTRBMT mice given
Ki20227 were 80% lower than those in matched mice receiving
vehicle (Figure 5F). These findings indicate that antagonizing
CSF1R can sustain DT-induced microglia depletion in the MBH
of DTRBMT mice.
Microglial Content in the MBH Dictates the Intensity of
the Inflammatory Response to Excess Dietary SFAs
We next tested the impact of manipulating microglial content
upward or downward specifically in the MBH (Figure 6A) on
the intensity of hypothalamic inflammation induced by excess
consumption of dietary SFAs. Three days of SFA gavage
increased the mRNA levels of hypothalamic M1 markers simi-
larly in both DT-treated WTBMT mice and vehicle-treated
DTRBMT mice (Figure 6B) and to a degree similar to that seen
in untransplanted WT mice (Figure 2A). By contrast, DT-treated
DTRBMT mice in which microglial content in the MBHwas greatly
increased by postdepletive proliferation had an augmented
hypothalamic inflammatory response to SFA gavage (Figure 6B).
On the other hand, when MBH microglial depletion was sus-
tained by Ki20227 treatment, the inflammatory response to
SFA gavage within the hypothalamus was remarkably abol-
ished and not different from control mice gavaged with salinehors
Figure 5. Selectively and Stably Depleting Microglia in the MBH of DTRBMT Mice
(A) Hypothalamic sections 24 hr after BM-transplantedWT and DTRBMT mice were given DT (10 ng/g i.p.) daily for 3 days showing depletion of Iba1+ cells (green)
in DT-treated DTRBMT mice along with abnormal microglial morphology (inset).
(B and C) Reduction in (B) hypothalamic microglial number and (C) microglial mRNA levels (Iba1, Itgam), but not the astrocyte markerGfap in DT-treated DTRBMT
mice (n = 3/group; data shown are mean values ± SEM; *p < 0.05 versus control).
(D) Stabilization of microglial depletion in the MBH of DTRBMT mice by preventing postdepletive microglial proliferation (Iba1+/BrdU+ cells) with Ki-20227
treatment (30 mg/kg/day for 3 days post-DT).
(E) Quantification of (D) (n = 5/group; data shown are mean values ± SEM).
(F) Reduced microglial mRNA levels in hypothalami of DT-treated DTRBMT mice also treated with Ki20227 (data shown are mean values ± SEM; *p < 0.05 versus
control).
See also Figure S5.(Figure 6B). These data indicate that the microglial content of the
MBH dictates the intensity of the hypothalamic inflammatory
response to SFA excess.
Microglia Mediate Neuronal Injury Induced by Excess
Dietary SFAs in the MBH
We also tested the role of microglia in the response of neurons
in the MBH to excess SFA intake. Remarkably, depleting mi-Cell Recroglia from the MBH of DTRBMT mice nearly abolished the
marked induction of Hsp72 otherwise seen in ARC neurons
following enteric SFA gavage (Figures 6C–6E). Moreover,
when basal microglial content in the MBH was increased, the
neuronal stress response to enteric SFA challenge was accen-
tuated (Figure 6E) and extended beyond the ARC to affect
other hypothalamic regions, such as the VMH (not shown).
Taken together, these results indicate that microglia mediateports 9, 2124–2138, December 24, 2014 ª2014 The Authors 2131
Figure 6. Hypothalamic Microglial Content Modulates Inflammatory
Response and Neuronal Injury to Dietary SFAs
(A) Protocol for administering DT (10 ng/g i.p.) followed by enteric SFA
gavage under conditions where postdepletive microglial proliferation in the
MBH was allowed to occur or in which Ki20227 treatment sustained mi-
croglial depletion.
2132 Cell Reports 9, 2124–2138, December 24, 2014 ª2014 The Autthe mechanism by which excess SFA consumption triggers
neuronal stress in the MBH.
Microglia Mediate the Impact of Excess SFA
Consumption on Hypothalamic Function
Because enteric gavage with SFAs produced neuronal stress in
leptin-responsive ARC neurons, we wanted to test the effect of
microglial depletion on leptin signaling in the context of high
SFA consumption. Mice were fed a normal chow diet containing
PLX5622, a CSF1R antagonist with oral bioavailability superior to
that of Ki20227 and that inhibits the tyrosine kinase activity of
CSF1R at nanomolar concentrations (Cavnar et al., 2013; Coni-
glio et al., 2012; Hamilton and Achuthan, 2013). PLX5622 acts
similarly to other CSF1R blockers (Elmore et al., 2014; Zhang
et al., 2013a), one of which (PLX3397) was recently shown to
depletemicroglia inmice on its own (Elmore et al., 2014). Consis-
tent with this, feeding mice a diet containing PLX5622 depleted
over 98% of microglia within 7 days without altering circulating
monocyte numbers (Figures S7A and S7B).
We then supplemented the diet of PLX5622-treated and con-
trol mice with milk fat by twice-daily gavage for 10 days, after
which themice were injected with i.p. leptin. Interestingly, micro-
glial depletion in this context enhanced leptin-induced STAT3
activation by ARC neurons, indicating that microglia act to
restrain leptin responsiveness in the ARC when SFA consump-
tion is high (Figures 7A and 7B).
Based on our analysis of leptin signaling in the ARC, we
wondered whether microglia have a concomitant impact on
food intake, which is regulated by the hypothalamic actions of
leptin, when SFA intake is high. Whereas PLX5622-induced mi-
croglial depletion did not impact daily food intake in mice fed a
standard low-fat diet chow diet (Figure 7C), microglial depletion
progressively reduced daily food intake in mice consuming
excess SFAs (Figure 7D), a finding that was confirmed by placing
themice in metabolic cages (Figures 7E and 7F). Together, these
data indicate that microglia control hypothalamic function to
maintain consistent food intake specifically in the face of exces-
sive SFA consumption.
DISCUSSION
Diet-induced inflammation in the MBH is marked by an accumu-
lation of astrocytes and activated microglia, but it was unclear
what orchestrates this inflammation. Here, we identify microglia
as sensors activated by rising levels of dietary SFAs in the MBH(B) Analysis of M1 markers in DT-treated DTRBMT mice showing that the in-
flammatory response to SFA gavage is enhanced by increasing microglial
content in the MBH and abolished by depleting microglia from the MBH (DT-
treated WT and vehicle-treated CD11b-DTR mice as reference).
(C) Immunostaining of ARC sections illustrating induction of Hsp72 in NeuN+
cells by SFA gavage, the accentuation of SFA-induced neuronal stress by
increasing basalmicroglial content in theMBH, and the complete prevention of
SFA-induced neuronal stress by local depletion of microglia.
(D and E) Quantification of (C), showing reduced (D) Hsp72 intensity and (E)
percentage of Hsp72+/NeuN+ cells induced by microglial depletion in the
MBH.
Data shown are mean values ± SEM; n = 6/group; *p < 0.05 versus matched
control or as indicated and **p < 0.05 versus DTR control. See also Figure S6.
hors
Figure 7. Microglial Depletion Enhances Leptin Signaling and Decreases Food Intake in Response to Excess Dietary SFAs
(A) Hypothalamic sections frommice fed a chow diet or amatched diet compoundedwith PLX5622 for 7 days followed by continuation of the respective regimens
with milk fat (twice-daily gavage) supplementation for 10 more days showing pSTAT3 staining 45 min after injection with i.p. leptin (3 mg/kg) or vehicle.
(B) pSTAT3 quantification showing enhanced leptin responsiveness in the ARC of mice consuming excess milk fat in the setting of microglial depletion.
(C) Equivalent food intake in PLX5622-treated and control mice consuming chow alone.
(D) Reduced food intake in PLX5622-treated mice receiving SFA gavage for 8 days.
(E) Reduced food intake measured by metabolic cages in PLX5622-treated mice with excess SFA intake.
(F) Area under the curve (AUC) analysis for (E).
Data shown are mean values ± SEM; n = 6 mice/group; *p < 0.05. See also Figure S7.that control the intensity of a highly localized form of inflamma-
tion. In this setting, microglia mediate the stress-inducing effects
of dietary SFAs on neurons residing in the ARC and reduce their
responsiveness to leptin, thus impacting food intake. Metabolic
inflammation in the MBH occurs more acutely in response to the
steady consumption of excess saturated fat than in peripheral
tissues, where it occurs in conjunction with obesity. There is
interest in mitigating MBH inflammation due to this temporal pri-
macy and because it is linked to metabolic dysregulation. Our
findings provide strong mechanistic evidence to support target-
ing microglia to reach this objective.
Our focus on SFAs was prompted by a lipidomic analysis of
the brains of mice fed an HFD. Prior work showed that mice
consuming a lard-based diet (60% of calories from fat) for
3 months accumulate hypothalamic lipids, many of which are
linked to peripheral tissue inflammation and/or insulin resistanceCell Re(Borg et al., 2012). This lard-based diet also produced hypotha-
lamic inflammation in rats (Thaler et al., 2012). The mice in our
study were fed a high-SFA milk fat-based diet for only 28 days,
and gained much less weight than would have been seen with
a more chronic diet. Despite the short duration of this dietary
challenge, the mice in our study had altered levels of several lipid
species, including specific phospholipids, sphingolipids, ether
lipids, and fatty acids in both the cerebral cortex and the hypo-
thalamus. Most of diet-induced lipid alterations were direction-
ally similar in the hypothalamus and cortex, likely reflecting
common patterns of lipid metabolism throughout the brain.
On the other hand, C16:0 PA was the only lipid species that
was increased by diet specifically in the hypothalamus. This
finding is notable, as although the diet in this study (42% of
calories from fat) is less calorically dense than standard lard-
based HFDs, it is specifically enriched in SFAs (long-chainports 9, 2124–2138, December 24, 2014 ª2014 The Authors 2133
SFA: monounsaturated ratio of 2.3:1, as opposed to 1.4:1 in
the prior study), the most abundant of which is PA. The enrich-
ment of dietary PA specifically in the hypothalamus may reflect
the emerging concept that the MBH is more amenable to the en-
try of nutritional factors than other brain areas, allowing it to sam-
ple dietary composition in order to coordinate physiological
processes.
Our study also demonstrates that the transit of dietary SFAs
into the brain is fast enough to stimulate the rapid inflammatory
activation and proliferation of microglia previously reported
(Thaler et al., 2012). We used radiolabeling to show that satu-
rated fats flux into the brain within hours of enteral consumption,
and we used fluorescent labeling to show that fats are readily
transported into the hypothalamus by circulating lipoproteins
(VLDL in our model), where they are taken up by microglia. Other
work shows that hypothalamic microglia also accumulate immu-
noglobulin G in response to an HFD, supporting the concept that
these cells can sense peripheral signals in response to nutritional
and/or environmental changes (Yi et al., 2012).
Excess SFA consumption induced microglial activation in the
MBH despite controlling for total fat and caloric intake, and
without increasing body weight. These data support our in vitro
data, indicating that dietary SFAs directly stimulateM1 activation
of MBH microglia, whereas peripheral tissue inflammation may
depend, at least in part, on the presence of obesity. Additionally,
enteric SFAs induced MBH inflammation despite not increasing
circulating levels of inflammatory cytokines, indicating that SFA-
induced MBH inflammation is not a byproduct of systemic
inflammation.
Importantly, metabolic inflammation in the MBH could be
induced by enteric SFAs without the need for intravenous (i.v.)
or intracerebroventricular (i.c.v.) administration, underscoring
the physiological relevance of our findings to people, many of
whom consume high levels of saturated fat on a daily basis.
Our findings are supported by recent work showing that hypo-
thalamic microglial activity in obese mice is influenced by dietary
composition and by fat- and gut-derived hormonal cues, but not
body weight per se (Gao et al., 2014).
Tracking CCR2+ monocytes showed that accumulation of
MBH microglia in mice receiving SFA gavage was not due to
infiltrating monocytes differentiating into microglia-like cells.
Instead, our data suggest that this accumulation is due to local
proliferation in the MBH, a capacity that was inducible by
depleting hypothalamic microglia using Lip-CLO or DT. Indeed,
a nestin+ precursor cell type was recently found to be respon-
sible for microglial self-renewal and proliferation in mice (Elmore
et al., 2014), directly supporting this concept. Diet-induced mi-
croglial accumulation in the MBH is in some ways similar to
macrophage accumulation in the white adipose tissue, a pro-
cess also recently shown to involve local proliferation (Amano
et al., 2014).
We also observed that postdepletive microglial proliferation is
associated with the secretion of cytokines and chemokines inde-
pendent of inflammatory activation. For example, basal Il6
mRNA levels were slightly elevated in CD11c-DTR hypothalamic
slices following microglial depletion with DT. This was not seen
when microglia were depleted with clodronate, perhaps indi-
cating that postdepletive microglial proliferation is milder in this2134 Cell Reports 9, 2124–2138, December 24, 2014 ª2014 The Autmodel. Similarly, Ccl2 mRNA levels were elevated in the hypo-
thalami of DTRBMT treated with DT. It will be interesting to test
the role of cytokines and chemokines in modulating microglial
proliferation.
Do other cell types sense FAs in theMBH? Unlike SFAs, which
stimulated microglial M1 activation in culture, in hypothalamic
slices, and in the MBH of mice, monounsaturated FAs failed to
do so in any context. By contrast, monounsaturates given i.v.
or i.c.v. reduce food intake and hepatic glucose production in ro-
dents, whereas SFAs do not (Obici et al., 2002). Therefore,
whereas microglia sense SFA levels and transduce this into an
inflammatory response, other cell types in theMBHmay respond
tomonounsaturates. For example, neurons in theMBH are impli-
cated in sensing FAs (Lam et al., 2005), and neuronal lipoprotein
lipase may be needed for this sensing to occur (Wang et al.,
2011).
A recent study suggested that SFA treatment could induce
cytokine secretion by cultured astrocytes (Gupta et al., 2012).
However, eliminating microglia from astrocyte cultures is difficult
because astrocytes produce CSF-1, a potent microglial growth
factor (Hao et al., 1990), and traces of microglia in astrocyte
cultures can confound experimental results (Saura, 2007). We
treated CD11b-DTR astrocyte cultures with DT and WT astro-
cyte cultures with Lip-CLO to eliminate all microglia. In doing
so, we found that hypothalamic microglia, and not astrocytes,
secrete inflammatory cytokines when directly stimulated by
SFAs. This finding suggests that astrogliosis in the MBH under
conditions of dietary excess may be a response to signals
from activated microglia and/or neurons responding to meta-
bolic stress. Identifying such signals is a key area for exploration.
On the other hand, both astrocytes and microglia responded
to LPS, indicating that astrocytes can sense certain inflamma-
tory stimuli. Indeed, astrocyte activation, for example during
infection, may stimulate responses including cachexia, that are
distinct from those induced by microglial activation. Moreover,
emerging evidence suggests that crosstalk between M1-like mi-
croglia and astrocytes can amplify inflammatory responses and
synergistically increase the production of neurotoxic factors
(Pascual et al., 2012; Saijo et al., 2009). The significance of mi-
croglia-astrocyte crosstalk in SFA-induced MBH inflammation
remains to be defined.
Excess SFA consumption also specifically induced MBH neu-
rons to express the cellular stress chaperone Hsp72, a finding
with two possible interpretations. One is that neurons directly
respond to SFAs by expressing Hsp72 and producing factors
that attract local microglia and trigger their activation. Our find-
ings instead support the idea that neuronal stress in the MBH
is dictated by microglia responding directly to SFAs. Future
studies should focus on whether activated microglia mediate
SFA-induced neuronal stress through physical interaction, cyto-
kine secretion (supported by data shown here), or both.
Diet-induced obesity is associated with hyperphagia and
dysregulated hepatic glucose production, processes controlled
by neuronal circuits in the MBH that respond to afferent inputs
from leptin and insulin (Samuelsson et al., 2008). The current
study indicates that excessive SFA consumption can stimulate
microglia to alter the function of neurons within these circuits.
Specifically, we found that microglia are required for micehors
consuming excess saturated fat to maintain a consistent daily
food intake. Without microglia, mice with high SFA intake had
a progressive reduction in total daily food intake over several
days. Remarkably, microglial depletion did not impact food
intake in control mice. Together, these findings indicate that
while not a dominant determinant of food intake, microglia regu-
late the function of hypothalamic neurons controlling food intake
when SFA consumption is high.
ARC neurons that expressed Hsp72 in response to high SFA
consumption included those activated by leptin, a hormonal
regulator of food intake. Moreover, leptin signaling in the ARC
of mice consuming excess SFAs was enhanced when microglia
were depleted, highlighting the importance ofmicroglia-neuronal
crosstalk in the response to SFAs. Future research should focus
on the role of this crosstalk in long-term energy balance, meta-
bolic function, and the complications of dietary excess.
Beyond promoting pathology, it is intriguing to consider the
potential physiological role of microglial activation and prolifera-
tion in the MBH. Microglia respond rapidly to a variety of physi-
ological stimuli and are implicated in the acute remodeling of
neuronal circuits. It is therefore worth noting that systemic SFA
levels are elevated not only in the setting of obesity but also
following individual fatty meals. We observed the flux of dietary
fats into the brain, microglial activation, and neuronal stress in
the MBH following acute bouts of SFA intake. These factors
may act in concert to remodel hypothalamic circuitry and rapidly
tailor the response to dietary intake. Such remodeling may be
required, for example, to reduce satiety in predatory mammals
consuming a large meal after a prolonged fast or to allow new-
borns to thrive solely on maternal milk. If microglia help remodel
neuronal circuits under such circumstances, then the MBH
inflammation in obesity may reflect the hijacking of a physiolog-
ical process, as is suggested for metabolic inflammation in pe-
ripheral tissues.
Whereas hypothalamic inflammation induced by HFD is asso-
ciated with obesity, inflammation due to injury, infection, cancer,
or autoimmunity is paradoxically associated with cachexia and
weight loss. Our findings suggest this contrast may reflect differ-
ences in the amplitude of metabolic inflammation versus other
forms. For example high levels of IL-6, as seen in profound
inflammation, are implicated in reducing body weight (Franck-
hauser et al., 2008). Consistently, global Il6–/– mice are prone
to obesity, and forced overexpression of Il6 in the brain protects
against it (Hidalgo et al., 2010). On the other hand, we show that
hypothalamic Il6 levels are also increased by HFD; however, to a
potentially much smaller degree than that due to infection or
transgenic overexpression. Whereas IL-6 in the brain may pro-
duce cachexia when dramatically elevated or accompanied by
systemic inflammation, small rises in IL-6 specifically in the
MBH may produce different effects. This concept is analogous
to the low-grade nature of diet-induced inflammation in periph-
eral metabolic tissues (Gregor and Hotamisligil, 2011).
The current study also points to the promise of targeting mi-
croglia to control MBH inflammation. Prior approaches to alter
gene expression or deplete microglia have depended on admin-
istering reagents into the brain (Zhang et al., 2013b) that disrupt
the BBB and produce nonspecific inflammation. BBB disruption
also permits monocyte infiltration into the brain (Varvel et al.,Cell Re2012). We depleted and increased the basal number of quies-
cent microglia in the MBH without altering peripheral myeloid
cell numbers or injecting reagents into the brain. Indeed, i.p.
DT injection specifically targeted microglia in the MBH of
CD11b-DTRBMT mice, and microglial depletion in this model
was sustained by CSF1R antagonism.
Recent work using reporter mice shows that microglia, but not
neurons, express CSF1R in the adult brain, including the hypo-
thalamus (Erblich et al., 2011; Sierra et al., 2007). Highly potent
CSF1R antagonists are now being examined for their ability to
control microglial self-renewal, and one such agent was recently
shown to rapidly deplete microglia from the brains of mice by
blocking the proliferative capacity of localmicroglia-specific pro-
genitors (Elmore et al., 2014). As shown here, such tools repre-
sent a new way to limit microglial proliferation and hypothalamic
inflammation in the context of dietary excess.
The role of microglia in the MBH prompts comparisons
to macrophages in tissues, such as the adipose, liver, and skel-
etal muscle. Targeting macrophage activation ameliorates diet-
induced inflammation in these tissues and insulin resistance in
obese models. Diet-induced inflammation in the MBH precedes
that in peripheral tissues. Our finding that microglia mediate the
inflammatory impact of dietary SFAs and their effect on neuronal
function in theMBH suggests that targeting hypothalamicmicro-




All studies used male C57BL/6 mice. Slice studies and bone marrow (BM)
transplants used WT and CD11b-DTR mice, which have been used to deplete
CD11b-expressing cells (Cailhier et al., 2005; Duffield et al., 2005). CX3CR1-
GFP mice were used to confirm the effect of CSF1R antagonism on microglial
depletion in vivo. Primary microglia and astrocytes were from WT mice. Mice
were group housed (12 hr/12 hr light/dark) and age matched. Mice were fed
either a standard chow diet (13.2% of calories from fat; LabDiet 5053) or an
HFD containing extra calories from milk fat (HFD; 42% of calories from fat,
TD.88137; Harlan-Teklad). Anesthesia was by isoflurane or by 100 mg/kg ke-
tamine and 10 mg/kg xylazine or Avertin (terminal procedures). The University
of California San Francisco Institutional Animal Care and Use Committee
approved all procedures.
Measurements of Food Intake and Energy Metabolism
Metabolic parameters in mice were assessed using a Comprehensive Lab An-
imal Monitoring System (Columbus Instruments). Themice were singly housed
and received water and food ad libitum, along with enteric supplementation
with saline or milk fat twice a day (below). Cages were maintained at 20C–
22C under a 12:12 hr light-dark cycle (light period 07:00–19:00), and mice
were acclimatized for 48 hr before being studied. The cages continuously
weighed food for each mouse, and daily intake was measured as change in
food weight over successive 24 hr periods. All data were normalized to body
weight per the manufacturer’s guideline.
Lipidomic Analysis
For lipidomic analyses (Benjamin et al., 2013), mice underwent cervical dislo-
cation, and their brains were removed and flash frozen in liquid nitrogen. Hy-
pothalamic and cortical tissues were dissected and nonpolar lipids extracted
in chloroform:methanol:PBS (2:1:1 v:v:v;) containing 10 nmol each of C12:0
dodecylglycerol and pentadecanoic acid (internal standards). A total of 10 ml
of this extract was injected into a triple-quadrupole liquid chromatography tan-
dem mass spectrometry for targeted lipidomic analysis.ports 9, 2124–2138, December 24, 2014 ª2014 The Authors 2135
Gavage Feeding
Mice on a normal ad libitum chow diet received intragastric gavage with 200 ml
of clarified milk fat (>60% long-chain SFAs, 35% of which is C16:0 PA) or
isocaloric volumes of coconut oil (>70% short-chain SFAs, mostly lauric
acid [C12:0]) or olive oil (>80% unsaturated FAs, mostly oleic acid [OA,
C18:1]). Oils (versus PBS control) were delivered by gavage needle (Instech
Laboratories) in two equal doses (9:00 a.m. and 6:00 p.m.) per day for 3–
10 days. Each oil increased daily calories by 38%.
Bone Marrow Chimeras
Eight-week-old CD11b-DTRmice were anesthetized and individually placed in
lead tubes (RPI) to shield their heads and necks from irradiation (Mildner et al.,
2007). The mice were lethally irradiated in two 5 Gy doses 3 hr apart and un-
derwent BM transplant the next day by tail-vein injection with 33 106 BM cells
flushed from the femurs and tibiae of mice that did not express DTR, thus re-
stricting DTR expression to recipient microglia (DTRBMT). Donor BM was from
CCR2-RFPmice in order to track donor-derived leukocytes in recipient tissues
(Saederup et al., 2010). After transplant, DTRBMT andWTBMTmice received an-
tibiotics (polymyxin B and neomycin) for 1 month, and reconstitution efficiency
was confirmed by FACS.
Microglial Depletion
To specifically deplete hypothalamic microglia, DTRBMT mice were injected
i.p. with 10 ng/g body weight of DT (Sigma-Aldrich) in PBS every 24 hr for
three doses, and the mice were dissected either 3 or 10 days after the final
dose. To prevent proliferation of hypothalamic microglia following DT-
induced depletion in mice receiving oil gavage, a CSF1R tyrosine kinase in-
hibitor, Ki20227 (30 mg/kg/day in 0.5% methyl cellulose) was administrated
once orally during each day of the 3-day protocol. Microglia were also
depleted from mice by treatment with another CSF1R antagonist, PLX5622
(Plexxikon), formulated in AIN-76A rodent chow (Research Diets) at a dose
of 1.2 g/kg. Microglia were depleted by exposure to PLX5622 in this way
for 7 days.
Culture and Treatment of Primary Glia
Glial cultures were prepared as described previously (Deierborg, 2013). Cere-
bral cortices were harvested from postnatal day 1 (P1) to P4 pups, the
meninges and blood vessels were removed, and the parenchyma minced
and triturated in Dulbecco’s modified Eagle’s medium (DMEM) + GlutaMAX
(Invitrogen) with 4.5 g/l glucose, 10% fetal bovine serum, 100 U/ml penicillin,
and 0.1 mg/ml streptomycin. Suspended cells were filtered (70 mm) and plated
on poly-L-lysine-coated flasks with media replenished twice weekly, resulting
in mixed glial monolayers. Six to 10 days later, the flasks were shaken
(200 rpm) for 2 hr (37C) to specifically release microglia, which were replated.
Pure astrocyte cultures were obtained either using liposomal clodronate to re-
move residual adherent microglia from WT glial monolayers (Kumamaru et al.,
2012) or using DT (20 ng/ml) for 3 days to remove microglia in glial monolayers
from CD11b-DTRmice. Bothmicroglia and astrocyte cultures were 70%–80%
confluent prior to treatment with FAs, which were added to serum-free me-
dium as a 4:1 BSA complex (Listenberger et al., 2001).
Isolation of Hypothalamic Microglia from Adult Mice
Murine hypothalamic microglia were also isolated from PBS-perfused adult
brains as described previously (Cardona et al., 2006). At least five hypothalami
per group were pooled, digested for 30 min (37C) with 1 mg/ml collagenase
and 0.1 mg/ml DNase I, homogenized in Hank’s balanced salt solution, and
passed through a 70 mm strainer. Homogenates were then centrifuged at 500
3 g for 5 min, after which supernatants were removed and cells resuspended
in 37% isotonic Percoll. Cells were then passed through a discontinuous Per-
coll gradient (70%, 37%, 30%, and 0% layers) by centrifugation (500 3 g for
30 min), and microglia were collected from the 70%–37% interphase. Extrac-
tions yielded 5 3 105 viable cells, of which 90% were CD11b+/CD45low
microglia.
Hypothalamic Organotypic Slice Culture
Organotypic hypothalamic slices were isolated and cultured essentially
as described previously (Fukuda et al., 2008). WT and CD11b-DTR pups2136 Cell Reports 9, 2124–2138, December 24, 2014 ª2014 The Aut(P8–P11) underwent rapid brain dissection and removal. Hypothalami were
blocked and cut into 300 mm sections on a vibratome (VT1000 S, Leica) while
floating in chilled Gey’s balanced salt solution with glucose (0.5%) and KCl
(30 mM). Coronal slices containing the ARC and ME were then placed on
0.4 mm Millicell-CM filters (Millipore) and cultured at an air-media interface in
DMEM/F12 (1:1) supplemented with heat-inactivated horse serum (25%),
glucose (32 mM), and GlutaMAX (2 mM). Cultures were maintained for
10 days, and medium was replaced three times a week. Slices were incubated
overnight in low-serum (2.5%) medium with 2 mM GlutaMAX prior to
experiments.
Depleting Microglia from Hypothalamic Slice Cultures
Microglia were depleted from hypothalamic slice cultures without altering
other cell types by modifying prior approaches (Okamura et al., 2012; Vinet
et al., 2012). In one method, slices were incubated with 0.5 mg/ml of liposomal
clodronate (Lip-CLO) or control liposomes (Lip-C) (Encapsula NanoSciences)
for 48 hr. Slices were then washed in PBS to remove residual liposomes,
placed in fresh medium, and studied 48 hr later. In another method, CD11b-
DTR slices were treated with 10 ng/ml DT for 48 hr, after which washing and
subsequent culture were as for the first method. Vehicle-treated CD11b-
DTR slices and DT-treated WT slices were controls.
Immunohistochemistry
Anesthetizedmice were perfusedwith 4%paraformaldehyde in 100mMphos-
phate buffer, and their brains were dissected, postfixed in the same fixative
overnight (4C), and immersed in 30% sucrose. Hypothalami were then sepa-
rated from other regions, embedded in optimal cutting temperature com-
pound, immediately frozen on dry ice, and stored at80C. Next, 10-mm-thick
hypothalamic coronal sections were cut on a cryostat, blocked for 1 hr with 5%
BSA in PBS containing 0.1% Triton X-100, and incubated with primary anti-
bodies (Supplemental Experimental Procedures) overnight at 4C. TUNEL as-
says were done using the In situ Cell Death Detection Kit Fluorescein (Roche)
per the manufacturer’s instructions, and sections were washed three times
with 0.05% Tween 20 in PBS and incubated with secondary antibodies for
1 hr. Images were acquired with a fluorescence- (Olympus BX51, DP71) or
confocal laser-scanning microscope (Leica TCS SP5).
Immunoblot
Proteins were extracted by homogenizing cells in RIPA buffer with 1% NP-
40, 1% sodium deoxycholate, 0.1% SDS, 1 mM Na3VO4, 1 mM PMSF,
and a protease inhibitor cocktail (Sigma)] at 4C. Homogenates were then
centrifuged at 12,000 3 g for 10 min, and protein concentrations from super-
natants were quantified (BCA Kit; Thermo Scientific; Supplemental Experi-
mental Procedures). Leptin-induced STAT3 phosphorylation (pSTAT3) was
measured in mice fasted for 16 hr, injected with i.p. leptin (3 mg/kg) or saline,
and perfused 45 min later. Hypothalamic homogenates were then made as
above.
Cytokine and Chemokine Measurements
Levels were measured by ELISA (eBioscience), using the manufacturer’s
instructions.
Real-Time Quantitative PCR
Hypothalamic RNA was extracted in TRIzol (per the manufacturer’s instruc-
tions), quantified by spectrophotometry, and reverse transcribed (SuperScript
III; random hexamers) to make cDNA. Quantitative PCR was performed using
an ABI Prism 7900 HT machine and SYBR green detection of amplicons
(Applied Biosystems). Relative mRNA abundance was normalized to cyclophi-
lin by the DDCT method (per the manufacturer) and analyzed using the
Sequence Detection System software (SDS version 2.2; Applied Biosystems).
Primer sequences are listed in Table S1.
Statistics
Data are presented as the mean ± SEM. Two groups were compared using
two-tailed Student’s t tests. For more than two groups, one- or two-way
ANOVA was used, as appropriate, followed by post hoc adjustment. All ana-
lyses were performed with GraphPad software.hors
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